Authors


K. Jack Ishak, PhD

Latest:

Persistence With Antiarrhythmics and the Impact on Atrial Fibrillation–Related Outcomes

Retrospective analysis of claims data showed that persistence with amiodarone and sotalol was generally poor.



Ned Milenkovich, PharmD, JD

Latest:

Because Ned Said: As the Election Looms, Will Drug Price Negotiations Sway Voters?

Although patients hope for reduced costs, Pharma’s reaction to the IRA remains to be seen.


Max Greenlee, PharmD candidate

Latest:

Pain Management: The Pharmacist's Evolving Role

Pharmacists can help minimize risk for patients using pain medications.


Michael Munsell, BA

Latest:

Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients

An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.


Raquib Zaman, PharmD Candidate

Latest:

Successful Implementation of Student-Driven Virtual Transitions of Care Model During the COVID-19 Pandemic

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.


Brian M. Calimlim, MS

Latest:

Out-of-Pocket Healthcare Expenditures and Caps in Patients With Chronic Conditions

A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.



J. Steven Hata, MD, MS

Latest:

Cost-Effectiveness of Stress Ulcer Prophylaxis: Role of Proton Pump Inhibitors

Proton pump inhibitors are cost-effective options for stress ulcer prophylaxis.


Matthew R. Reynolds, MD, MSc

Latest:

Economic Burden of Atrial Fibrillation: Implications for Intervention

Because the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.


Colleen Hall

Latest:

CDC's ACIP Recommends Expanded HPV Vaccine Age Range for Some

The advisory board voted unanimously on Wednesday to recommend HPV vaccines for people through age 26.


David D. Pope, PharmD, CDE

Latest:

Here’s to Our Local Heroes: America’s Pharmacists

We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.


Adrianne C. Feldstein, MD, MS

Latest:

Assessing the Association Between Medication Adherence and Glycemic Control

Among a population of adult patients with type 2 diabetes, adherence to oral hypoglycemic medications is independently associated with poor glycemic control, even after adjusting for patient-level covariates.


Lucinda L. Maine, PhD, RPh

Latest:

Know No Limits: Future Pharmacy Careers

How many career paths are open to today’s pharmacy graduates?


Phil Hagerman, RPh

Latest:

Specialty Pharmacy: An Industry at Warp Speed

No other industry is moving at this warp speed or reaching into so many new frontiers. Here's what one industry leader has to say about today's landscape and what needs to happen for the specialty pharmacy industry to continue to thrive.


Joseph L. Fink III, BSPharm, JD, DSC (HON)

Latest:

Two Laws Expand Protections for Nursing Employees

Creating additional space for nursing mothers can be challenging in small pharmacies





Andrew J. King, MS

Latest:

Self-Reported Plan Switching in Medicare Part D: 2006-2010

Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.



Ray Glaser, PharmD

Latest:

Patient Communication Strategies for Boosting HPV Vaccination Coverage

Pharmacists have long been considered among the most accessible and trusted health care advisers.


Bruce Feinberg, DO, Vice President

Latest:

Trends That Will Affect Specialty Health Care Into the Future 

Current developments and innovations that will shape the future of specialty pharmacy.


Kwan Y. Lee, PhD

Latest:

Examining Part D Beneficiaries' Medication Use in the Doughnut Hole

The authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.


Tzippora Halpert, PharmD Candidate

Latest:

National Panel Updates Its Asthma Guideline

The National Asthma Education and Prevention Program's Expert Panel has issued revised guidelines for treating asthma in children and adults.


Andrea L. Leschak, PharmD

Latest:

Case Studies (July 2016)

What should these pharmacists do?


Wesley Sparkmon, MPH, CPhT

Latest:

Prescription Validation Is a Critical Task

Pharmacists count on techs’ help to complement their knowledge and ease their burden


Eberechukwu Onukwugha, PhD, MS

Latest:

Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin

Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.


Nicole Griffith, PharmD

Latest:

Choose the Most Appropriate Therapy to Fight Influenza

Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.


Kristy Malacos, MS, CPhT

Latest:

Changes in the Technician Profession

The pharmacy technician profession is continuously evolving, with increases in medication safety standards bringing about changes in technician requirements.